NASDAQ:MNLO - Menlo Therapeutics Price Target & Analyst Ratings

$4.15
+0.36 (+9.50 %)
(As of 08/20/2019 04:00 PM ET)
Today's Range
$3.95
Now: $4.15
$4.40
50-Day Range
$3.11
MA: $4.22
$5.99
52-Week Range
$2.69
Now: $4.15
$12.00
Volume2,776 shs
Average Volume45,166 shs
Market Capitalization$99.39 million
P/E RatioN/A
Dividend YieldN/A
Beta2.39

Analyst Ratings

Menlo Therapeutics (NASDAQ:MNLO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Menlo Therapeutics in the last 12 months. Their average twelve-month price target is $16.00, suggesting that the stock has a possible upside of 285.54%. The high price target for MNLO is $25.00 and the low price target for MNLO is $7.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.752.752.80
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $16.00$20.3333$20.3333$18.00
Price Target Upside: 285.54% upside190.48% upside190.48% upside153.16% upside

Menlo Therapeutics (NASDAQ:MNLO) Consensus Price Target History

Menlo Therapeutics (NASDAQ:MNLO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/2/2019Cantor FitzgeraldReiterated RatingBuy$25.00MediumView Rating Details
10/9/2018Jefferies Financial GroupLower Price TargetHold$7.00LowView Rating Details
7/24/2018Roth CapitalInitiated CoverageBuy$29.00HighView Rating Details
7/24/2018KeyCorpInitiated CoverageBuyHighView Rating Details
4/25/2018GuggenheimReiterated RatingBuy$11.00HighView Rating Details
2/20/2018JMP SecuritiesInitiated CoverageMkt Outperform ➝ Outperform$44.00 ➝ $44.00HighView Rating Details
2/20/2018Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$48.00HighView Rating Details
(Data available from 8/20/2017 forward)
This page was last updated on 8/20/2019 by MarketBeat.com Staff

Featured Article: Reverse Stock Split

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel